Fabrazyme

In the US, Fabrazyme (agalsidase beta systemic) is a member of the drug class lysosomal enzymes and is used to treat Fabry Disease.

US matches:

UK matches:

Ingredient matches for Fabrazyme

Agalsidase Beta

Agalsidase Beta is reported as an ingredient of Fabrazyme in the following countries:

  • Australia
  • Austria
  • Belgium
  • Canada
  • Chile
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Israel
  • Italy
  • Japan
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Serbia
  • Slovakia
  • Slovenia
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Turkey
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web5)